General
dsm-firmenich wraps up €1.08 billion share buyback ahead of schedule
The company announced its plan “to repurchase ordinary shares with an aggregate market value of €1 billion and reduce its issued capital” on February 13, 2025,
-
By ICN Bureau | December 04, 2025
dsm-firmenich, a global leader in nutrition, health, and beauty, has completed its share repurchase program, totaling €1.08 billion—well ahead of its original target date of January 2026.
On February 13, 2025, the company announced its plan “to repurchase ordinary shares with an aggregate market value of €1 billion and reduce its issued capital.” It later added another €80 million in repurchases “to cover commitments under the Group’s share-based compensation plans.”
According to regulatory filings, between November 24 and December 1, 2025, dsm-firmenich repurchased 450,950 shares at an average price of €70.96 per share, amounting to €32.0 million.
The completed program saw a total of 12,930,796 shares bought back at an average price of €83.52, for a total outlay of €1.08 billion. Of these, 881,355 shares were repurchased “to cover commitments under the Group’s share-based compensation plans,” while 12,049,441 shares were repurchased “for capital reduction purposes.”
Looking ahead, dsm-firmenich “intends to cancel 12,049,441 shares in the first quarter of 2026.” This move will shrink the company’s issued shares by approximately 4.5%, from 265,676,388 to 253,626,947 shares.
_195_291.jpg)
